These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 27053094)

  • 1. Frequency of methotrexate intolerance in rheumatoid arthritis patients using methotrexate intolerance severity score (MISS questionnaire).
    Fatimah N; Salim B; Nasim A; Hussain K; Gul H; Niazi S
    Clin Rheumatol; 2016 May; 35(5):1341-5. PubMed ID: 27053094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS).
    Amaral JM; Brito MJM; Kakehasi AM
    Adv Rheumatol; 2020 Aug; 60(1):43. PubMed ID: 32843102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing methotrexate intolerance and its prevalence in rheumatoid arthritis: Development and validation of the MISA questionnaire.
    Vijaykumar D; Dhir V; Jain S; Pai V; Kaur J; Naidu GS; Sharma A; Khanna Sharma S; Jain S
    Int J Rheum Dis; 2021 Oct; 24(10):1294-1301. PubMed ID: 34432365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of methotrexate intolerance among patients with rheumatoid arthritis using the Arabic version of the methotrexate intolerance severity score.
    Albaqami J; Alshalhoub R; Almalag H; Dessougi M; Al Harthi A; Bedaiwi MK; Omair MA
    Int J Rheum Dis; 2019 Aug; 22(8):1572-1577. PubMed ID: 31245906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Ondansetron in Reducing Methotrexate Intolerance in Patients with Inflammatory Arthritis.
    Saif S; Kakalia S; Kitchlew R; Khan HA; Fida S; Siddique M
    J Coll Physicians Surg Pak; 2022 Oct; 32(10):1308-1312. PubMed ID: 36205276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Shea B; Swinden MV; Tanjong Ghogomu E; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD000951. PubMed ID: 23728635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate intolerance in oral and subcutaneous administration in patients with juvenile idiopathic arthritis: a cross-sectional, observational study.
    van Dijkhuizen EH; Pouw JN; Scheuern A; Hügle B; Hardt S; Ganser G; Kümmerle-Deschner JB; Horneff G; Holzinger D; Bulatović Ćalasan M; Wulffraat NM
    Clin Exp Rheumatol; 2016; 34(1):148-54. PubMed ID: 26843067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration.
    Fráňová J; Fingerhutová Š; Kobrová K; Srp R; Němcová D; Hoza J; Uher M; Saifridová M; Linková L; Doležalová P
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):36. PubMed ID: 27301536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The time course of gastric methotrexate intolerance in patients with rheumatoid arthritis and psoriatic arthritis.
    Dalkilic E; Sahbazlar M; Gullulu M; Yavuz M; Dilek K; Ersoy A; Ozkaya G; Yurtkuran M
    Mod Rheumatol; 2013 May; 23(3):525-8. PubMed ID: 22752502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis.
    Ćalasan MB; van den Bosch OF; Creemers MC; Custers M; Heurkens AH; van Woerkom JM; Wulffraat NM
    Arthritis Res Ther; 2013; 15(6):R217. PubMed ID: 24345416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceptions of methotrexate use in rheumatoid arthritis by rheumatologists and their patients: an Australian survey study.
    Nash P; Nicholls D
    Int J Rheum Dis; 2013 Dec; 16(6):652-61. PubMed ID: 24382276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of methotrexate in combination with other non-biologic disease-modifying antirheumatic drugs (DMARDs) in treatment of rheumatoid arthritis.
    Castrejón I; Gibson KA; Pincus T
    Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S20-8. PubMed ID: 24219037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of oral methotrexate intolerance in Japanese adult patients with rheumatoid arthritis.
    Kanda M; Sato M; Nagahata K; Naishiro Y; Murakami R; Honda S; Suzuki C
    Int J Rheum Dis; 2024 Jan; 27(1):e15029. PubMed ID: 38287557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate intolerance in the treatment of rheumatoid arthritis (RA): effect of adding caffeine to the management regimen.
    Malaviya AN
    Clin Rheumatol; 2017 Feb; 36(2):279-285. PubMed ID: 27596742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
    Müller RB; von Kempis J; Haile SR; Schiff MH
    Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary methotrexate dosage in rheumatoid arthritis, in patients treated for at least 6 months: a potential marker of adherence.
    Théate N; Geoffroy M; Kanagaratnam L; Gozalo C; Charlot I; Bolko L; Hittinger-Roux A; Djerada Z; Salmon JH
    RMD Open; 2024 May; 10(2):. PubMed ID: 38772677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effects of low dose methotrexate in rheumatoid arthritis patients.
    Gilani ST; Khan DA; Khan FA; Ahmed M
    J Coll Physicians Surg Pak; 2012 Feb; 22(2):101-4. PubMed ID: 22313647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression.
    Wells AF; Westhovens R; Reed DM; Fanti L; Becker JC; Covucci A; Keystone EC
    J Rheumatol; 2011 Nov; 38(11):2362-8. PubMed ID: 21885491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARI study.
    Idolazzi L; Adami S; Capozza R; Bianchi G; Cozzolongo A; Epis O; Fusaro E; Lapadula G; Migliore A; Pellerito R; Pucino A; Sinigaglia L; Visalli E; Rossini M
    Clin Exp Rheumatol; 2015; 33(6):895-9. PubMed ID: 26690890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.